Pacific Biosciences Of California (PACB) Treasury Shares (2018 - 2026)

Pacific Biosciences Of California's Treasury Shares history runs 9 years deep, the most recent figure standing at $19.2 million for Q1 2026.

• In Q1 2026, Treasury Shares rose 4804.59% year-over-year to $19.2 million; the TTM figure through Mar 2026 stood at $19.2 million (up 4804.59% YoY), while the FY2025 annual figure was $392000.0, changed 0.0% from the prior year.
• Treasury Shares was $19.2 million for Q1 2026 at Pacific Biosciences Of California, up from $392000.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $19.2 million in Q1 2026 to a low of $8392.0 in Q2 2022.
• Historically, Treasury Shares has averaged $8.4 million across 5 years, with a median of $8.8 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Treasury Shares tumbled 99.88% in 2022, then jumped 150555.39% in 2023.
• A 5-year view of Treasury Shares shows it stood at $8.7 million in 2022, then slumped by 93.76% to $541000.0 in 2023, then decreased by 27.54% to $392000.0 in 2024, then changed by 0.0% to $392000.0 in 2025, then surged by 4804.59% to $19.2 million in 2026.
• The last three Treasury Shares figures came in at $19.2 million (Q1 2026), $392000.0 (Q4 2025), and $18.1 million (Q3 2025), per Business Quant data.